KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intuitive Surgical (ISRG) Change in Accured Expenses (2016 - 2025)

Intuitive Surgical (ISRG) has 17 years of Change in Accured Expenses data on record, last reported at $107.5 million in Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 35.71% year-over-year to $107.5 million; the TTM value through Dec 2025 reached $112.7 million, up 4.06%, while the annual FY2025 figure was $112.7 million, 4.06% up from the prior year.
  • Change in Accured Expenses reached $107.5 million in Q4 2025 per ISRG's latest filing, up from $40.9 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $189.4 million in Q2 2024 and bottomed at -$271.2 million in Q1 2024.
  • Average Change in Accured Expenses over 5 years is $21.4 million, with a median of $49.9 million recorded in 2022.
  • The widest YoY moves for Change in Accured Expenses: up 1077.88% in 2022, down 224.13% in 2022.
  • A 5-year view of Change in Accured Expenses shows it stood at $21.1 million in 2021, then skyrocketed by 184.83% to $60.1 million in 2022, then increased by 2.5% to $61.6 million in 2023, then soared by 171.43% to $167.2 million in 2024, then plummeted by 35.71% to $107.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $107.5 million in Q4 2025, $40.9 million in Q3 2025, and $82.4 million in Q2 2025.